No abstract available.
Laryngectomy* ; Rehabilitation* ; Voice*

No abstract available.
Salivary Ducts*

No abstract available.
Giant Lymph Node Hyperplasia* ; Neck*

No abstract available.
Head* ; Myocutaneous Flap* ; Neck*

No abstract available.
Mouth Floor*

Tuberculosis of the upper respiratory tract is an uncommon disease, and the nasopharynx is particulary a rare site. Tuberculosis of the nasopharynx is mainly secondary infection from pulmonary tuberculosis via contagious, hematogenous or lymphogenous routes. The nasopharynx may be a portal entry for tubercle bacilli in patients who develope cervical lymphadenitis. Involvement of the nasopharynx by tuberculosis may be underdiagnosed because it does not produce obvious symptoms or phyiscal signs. Recently authors experinced a case of nasopharyngeal tuberculosis, here we present this case with a review of literature.
Coinfection ; Humans ; Lymphadenitis ; Nasopharynx ; Respiratory System ; Tuberculosis* ; Tuberculosis, Pulmonary

Keratoacanthoma(KA) is a rapidly growing benign cutaneous neoplasm, usually occurring on sunexposed sites in elderly people, and it has a close clinical and pathologic resemblance to squamous cell carcinoma. Giant KA of the lower lip is extremely rare. Various treatment modalities have been reported including radiation therapy, systemic oral retinoids, and the intralesional application of 5-fluorouracil(5-FU), methotrexate(MTX) or interferon alpha-2a. Excisional surgery, however, remains the treatment of choice for the majority of KA. The disadvantages of excision are the possible requirement for extensive reconstructive surgery and the resultant cosmetic or functional deficit. Recently, we experienced a case of giant KA of the lower lip in a 60-year-old male, and he was treated successfully with intralesional methotrexate. Now we report the case with a brief review of literature.
Aged ; Carcinoma, Squamous Cell ; Humans ; Interferons ; Keratoacanthoma* ; Lip* ; Male ; Methotrexate* ; Middle Aged ; Retinoids

BACKGROUND AND OBJECTIVES: Normal angiogenesis occurs as a part of the body's repair processes like the healing of wounds and fractures. By contrast, uncontrolled angiogenesis can often be pathological. Vascular remodelling could therefore play an important role in the growth process of solid tumors. The aim of this study was to detect the expression of platelet-derived endothelial cell growth factor (PD-ECGF), basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF), and investigate the correlation between these factors. Also, we studied the relationships between the expressions of these factors and the clinical stage, nodal involvement, and histologic grade in the squamous cell carcinoma of larynx. MATERIALS AND METHOD: The authors examined the expression of three angiogenic factors in specimens of laryngeal squamous cell carcinoma (n=17). The mRNA expressions of angiogenic factors were detected by the semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR). Statistics were analysed using the Fisher's exact test, the Wilcoxon signed rank test, and the Spearman correlation coefficiency. RESULTS: PD-ECGF and bFGF were significantly higher in the stages III and IV cancers than in the stages I and II cancers, and thus shows that bFGF was related to severity of the nodal involvement. The expression of more than one factor was significantly related with stages III and IV cancer. PD-ECGF and VEGF were related with each other. CONCLUSION: The authors suggest that angiogenic factors, especially, PD-ECGF and bFGF, may be used as prognostic factors for the squamous cell carcinoma of larynx.
Angiogenesis Inducing Agents ; Carcinoma, Squamous Cell* ; Endothelial Cells* ; Fibroblast Growth Factor 2 ; Fibroblasts* ; Larynx* ; RNA, Messenger ; Thymidine Phosphorylase ; Vascular Endothelial Growth Factor A ; Wounds and Injuries

Branchio-oto-renal (BOR) syndrome is a clinically heterogeneous autosomal dominant form of syndromic hearing loss characterized by variable hearing impairment, malformations of the pinnae, the presence of branchial arch remnants, and various renal abnormalities. BOR syndrome is caused by mutations in EYA1 and SIX1, which are critical to organogenesis and are expressed together in developing otic, branchial, and renal tissue. Branchio-otic (BO) syndrome comprises branchial fistulas and preauricular pits, but lacks renal anomalies. We present a case of BO syndrome in 30year-old man with a review of the literature.
Branchial Region ; Branchio-Oto-Renal Syndrome ; Branchioma ; Fistula ; Hearing Loss ; Organogenesis

BACKGROUND AND OBJECTIVES: Although there are a number of reports concerned with the role of immunity in the sudden onset of progressive sensorineural hearing loss, there are only a few references dealing with the involvement of immuneme- mediated mechanism in sudden deafness. This study was performed to define the alteration of peripheral blood T lymphocyte subsets in a group of patients with sudden deafness. MATERIALS AND METHODS: The study was carried out prior to the start of and after the steroid therapy. Thirty two patients (18 men and 14 women : mean age, 43.19 years) were compared with 15 healthy control subjects (7 men and 8 women : mean age, 44 years). Patients were divided into 2 groups according to their responses to the steroid therapy. RESULTS: A decreased number of both CD4' helper cells (38.44% vs 42.36%; p < 0.05) was observed in the patient group compared with those in the control group. In the group of patients who showed good response to the steroid therapy, there was a tendency toward normalization of the CD4 (pretreatment, 34.41%; posttreatment, 43.91%) cell counts, with a slight decrease in the CD8' population (pretreatment, 20.66%: posttreatment, 19.16%). However, there was no significant increment in patients with the poorer response when there was a increase in the CD4' (pretreatment, 32.12% ; posttreatment, 38.6%) cell counts after the steroid therapy. CONCLUSION: These results demonstrate that there is significant abnormality in the subpopulations of lymphocytes in patients with sudden hearing loss, suggesting the immune system as a possible etiopathogenic factor in this entity.
Cell Count ; Female ; Flow Cytometry* ; Hearing Loss, Sensorineural ; Hearing Loss, Sudden* ; Humans ; Immune System ; Lymphocytes ; Male ; T-Lymphocyte Subsets* ; T-Lymphocytes, Helper-Inducer